TAUNS Laboratories,Inc. Income Statement

Financials in millions JPY. Fiscal year is July - June.

Millions JPY. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Revenue	18,628	18,435	15,673
Revenue Growth (YoY)	1.05%	17.62%	-
Cost of Revenue	5,853	5,937	6,473
Gross Profit	12,775	12,498	9,200
Selling, General & Admin	4,061	4,045	3,819
Operating Expenses	4,510	4,468	4,233
Operating Income	8,265	8,030	4,967
Interest Expense	-102.9	-31.21	-21.81
Interest & Investment Income	14.15	7.69	7.47
Other Non Operating Income (Expenses)	43.68	-165.95	0.51
EBT Excluding Unusual Items	8,220	7,841	4,953
Gain (Loss) on Sale of Investments	-	-1.67	-297.85
Gain (Loss) on Sale of Assets	-18.09	-6.16	-0.74
Other Unusual Items	0	1.89	-
Pretax Income	8,202	7,835	4,655
Income Tax Expense	1,886	2,061	1,620
Net Income	6,315	5,774	3,035
Net Income to Common	6,315	5,774	3,035
Net Income Growth	9.38%	90.26%	-
Shares Outstanding (Basic)	102	100	100
Shares Outstanding (Diluted)	107	107	100
Shares Change (YoY)	0.26%	6.94%	-
EPS (Basic)	62.07	57.74	30.35
EPS (Diluted)	58.90	53.99	30.35
EPS Growth	9.09%	77.90%	-
Free Cash Flow	2,137	6,182	-4,247
Free Cash Flow Per Share	19.94	57.80	-42.47
Dividend Per Share	18.000	10.650	-
Dividend Growth	69.01%	-	-
Gross Margin	68.58%	67.80%	58.70%
Operating Margin	44.37%	43.56%	31.69%
Profit Margin	33.90%	31.32%	19.36%
Free Cash Flow Margin	11.47%	33.53%	-27.10%
EBITDA	8,980	8,706	5,607
EBITDA Margin	48.21%	47.23%	35.78%
D&A For EBITDA	715.43	676.16	639.97
EBIT	8,265	8,030	4,967
EBIT Margin	44.37%	43.56%	31.69%
Effective Tax Rate	23.00%	26.30%	34.80%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.